Unknown

Dataset Information

0

Multifaceted immune dysregulation characterizes individuals at-risk for rheumatoid arthritis.


ABSTRACT: Molecular markers of autoimmunity, such as antibodies to citrullinated protein antigens (ACPA), are detectable prior to inflammatory arthritis (IA) in rheumatoid arthritis (RA) and may define a state that is 'at-risk' for future RA. Here we present a cross-sectional comparative analysis among three groups that include ACPA positive individuals without IA (At-Risk), ACPA negative individuals and individuals with early, ACPA positive clinical RA (Early RA). Differential methylation analysis among the groups identifies non-specific dysregulation in peripheral B, memory and naïve T cells in At-Risk participants, with more specific immunological pathway abnormalities in Early RA. Tetramer studies show increased abundance of T cells recognizing citrullinated (cit) epitopes in At-Risk participants, including expansion of T cells reactive to citrullinated cartilage intermediate layer protein I (cit-CILP); these T cells have Th1, Th17, and T stem cell memory-like phenotypes. Antibody-antigen array analyses show that antibodies targeting cit-clusterin, cit-fibrinogen and cit-histone H4 are elevated in At-Risk and Early RA participants, with the highest levels of antibodies detected in those with Early RA. These findings indicate that an ACPA positive at-risk state is associated with multifaceted immune dysregulation that may represent a potential opportunity for targeted intervention.

SUBMITTER: James EA 

PROVIDER: S-EPMC10665556 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications


Molecular markers of autoimmunity, such as antibodies to citrullinated protein antigens (ACPA), are detectable prior to inflammatory arthritis (IA) in rheumatoid arthritis (RA) and may define a state that is 'at-risk' for future RA. Here we present a cross-sectional comparative analysis among three groups that include ACPA positive individuals without IA (At-Risk), ACPA negative individuals and individuals with early, ACPA positive clinical RA (Early RA). Differential methylation analysis among  ...[more]

Similar Datasets

| S-EPMC3111926 | biostudies-literature
| S-EPMC7966707 | biostudies-literature
| S-EPMC8596438 | biostudies-literature
| S-EPMC4840970 | biostudies-literature
| S-EPMC11906351 | biostudies-literature
| S-EPMC10844292 | biostudies-literature
| S-EPMC5741901 | biostudies-literature
2022-09-01 | E-MTAB-11874 | biostudies-arrayexpress
| S-EPMC11910230 | biostudies-literature
2023-12-21 | GSE245403 | GEO